வாரன் வாங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roundup: Australian startup s COVID-19 diagnosis tool, Vocera inks distribution deal with Wavelink and more briefs

Australian legal tech startup creates COVID-19 diagnosis tool Rulestar has used its automation platform to turn a static flowchart about COVID-19 diagnosis into an online tool. The startup, whose platform is used to automate complex legal documents, said the new diagnosis tool will help exhausted medical workers in expediting decision-making and raising the quality of their decisions. We looked up what s involved in triaging a potential [c]oronavirus patient: the logic isn t simple. We figured that it s dangerous to expect exhausted and stressed-out frontline workers to follow something like that , Rulestar Managing Director David Lipworth said in a statement. The company also announced it will open its platform globally for do-it-yourself automation across all industries.

David lipworthWarren wangAl zhangVocera communicationsRulestar managing director david lipworthAlcatel lucent enterpriseGeneral atlanticMedtech chairmanUnited imaging healthcareUnited imagingவாரன் வாங்அல் ஜாங்அல்காடெல் ழூசெந்த் நிறுவனஜநரல் அட்லாண்டிக்ஒன்றுபட்டது இமேஜிங் சுகாதாரம்ஒன்றுபட்டது இமேஜிங்

Genesis Medtech Group Raises Significa （JCN プレスリリース）

SINGAPORE, May 25, 2021 - ( JCN Newswire ) - Genesis MedTech Group ( Genesis ), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors. The funds will be used to drive the research and development of new products and the commercialization of existing products, as well as enable business expansion in emerging markets around the world. This acceleration in Genesis model is expected to enable patients and healthcare practitioners in emerging markets to access innovative medtech products that can address unmet needs faced day-to-day Genesis mission since its inception in 2019.

Sao pauloNew yorkUnited statesScience parkSingapore generalPalo altoHong kongMexico cityDistrito federalCity ofUnited kingdomJakarta rayaNoord hollandKaren chngWarren wangTracy huang

Genesis Medtech Group Raises Significant Growth Investment in Latest Round of Series B Financing

Genesis Medtech Group Raises Significant Growth Investment in Latest Round of Series B Financing
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Sao pauloNew yorkUnited statesScience parkSingapore generalPalo altoHong kongMexico cityDistrito federalCity ofUnited kingdomJakarta rayaNoord hollandKaren chngWarren wangTracy huang

Genesis MedTech Group Raises Latest Round of Series B Financing

Genesis MedTech Group Raises Latest Round of Series B Financing Genesis MedTech Group, a Singapore-based medical device company, completed a Series B growth financing of undisclosed amount. The round was led by General Atlantic with participation from CITIC Capital and the majority of shareholders from Series A. In conjunction with the funding, Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors. The company intends to use the funds to drive the research and development of new products and the commercialization of existing products, as well as enable business expansion in emerging markets around the world.

Warren wangLefei sunGenesis medtech groupGeneral atlanticManaging directorGenesis boardGenesis medtechImedtech groupவாரன் வாங்ஜநெஸிஸ் மெதிதேச் குழுஜநரல் அட்லாண்டிக்நிர்வகித்தல் இயக்குனர்ஜநெஸிஸ் பலகைஜநெஸிஸ் மெதிதேச்மெதிதேச் குழு

Genesis MedTech Group Raises Significant Growth Investment in Latest Round of Series B Financing

Published: May 24, 2021 SINGAPORE, May 23, 2021 /PRNewswire/ Genesis MedTech Group ( Genesis ), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors. The funds will be used to drive the research and development of new products and the commercialization of existing products, as well as enable business expansion in emerging markets around the world. This acceleration in Genesis model is expected to enable patients and healthcare practitioners in emerging markets to access innovative medtech products that can address unmet needs faced day-to-day-Genesis mission since its inception

New yorkUnited statesPalo altoHong kongMexico cityDistrito federalCity ofUnited kingdomJakarta rayaNoord hollandWarren wangLefei sunPrnewswire genesis medtech groupGenesis medtech groupImedtech groupManaging director